Sagimet Biosciences Inc (SGMT) USD0.0001 A
Sell:$4.90Buy:$5.22
$0.12
(2.37%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:$4.90
Buy:$5.22
Change:$0.12
(2.37%)
$0.12
(2.37%)Prices delayed by at least 15 minutes
Sell:$4.90
Buy:$5.22
Change:$0.12
(2.37%)
$0.12
(2.37%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 23 July 2024 | George W KembleExecutive Chairman | Sell Option/Award related | 23,625 | $3.17 | $74,829.83 | 118,693 |
| 19 July 2024 | Elizabeth RozekGeneral Counsel | Sell Tax related | 10,914 | $3.10 | $33,830.13 | 160,506 |
| 19 July 2024 | George W KembleExecutive Chairman | Sell Tax related | 14,062 | $3.10 | $43,604.86 | 142,318 |
| 19 July 2024 | Eduardo Bruno MartinsChief Level Officer | Sell Tax related | 8,357 | $3.10 | $25,910.04 | 81,213 |
| 26 March 2024 | David HappelPresident/CEO | Buy Regular purchase transaction | 12,100 | $5.27 | $63,730.70 | 639,200 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 23 July 2024 | George W KembleExecutive Chairman | Sell Option/Award related | 23,625 | $3.17 | $74,829.83 | 118,693 |
| 26 March 2024 | David HappelPresident/CEO | Buy Regular purchase transaction | 12,100 | $5.27 | $63,730.70 | 639,200 |
| 19 July 2024 | George W KembleExecutive Chairman | Sell Tax related | 14,062 | $3.10 | $43,604.86 | 142,318 |
| 19 July 2024 | Elizabeth RozekGeneral Counsel | Sell Tax related | 10,914 | $3.10 | $33,830.13 | 160,506 |
| 19 July 2024 | Eduardo Bruno MartinsChief Level Officer | Sell Tax related | 8,357 | $3.10 | $25,910.04 | 81,213 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.